Skip to content
GB
Company

Updated:

Generation Bio Co.

Generation Bio Co. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001733294, and its reported industry is...

Overview

Generation Bio Co. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001733294, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2025-03-13, it reported annual revenue of USD 19,892,000; net income of USD -131,668,000; total assets of USD 231,197,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
Generation Bio Co.
Former names in filing history
Generation Bio Co. (2018-03-05 to 2026-05-14)
Classification
Company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
Cambridge, MA, United States
Fiscal year end
December 31
SEC CIK
0001733294

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2024USD$19.9M-$131.7M$231.2M$76.3M-$88.6M
FY2023USD$5.9M-$126.6M$374.8M$66.4M-$52.7M
FY2022USD—-$136.6M$376.3M$93.2M-$102.4M
FY2021USD—-$119.2M$476.8M$375.1M-$91.8M

Recent SEC filings

FormFiledPeriodFiling
8-K8-K
8-K8-K
10-Q10-Q
8-K8-K
8-K8-K
10-Q10-Q
8-K8-K
8-K8-K
8-K8-K
10-Q10-Q
8-K8-K
DEF 14ADEF 14A

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Generation Bio Co. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

Generation Bio Co. | Cambridge Company | Altss